← Back to Clinical Trials
Recruiting NCT07824141

NCT07824141 Fall Prevention Pathways

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07824141
Status Recruiting
Phase —
Sponsor Emory University
Condition Old Age; Debility
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2025-09-29
Primary Completion 2028-09

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
The Fall Prevention Pathway (FPP)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2025-09-29 with a primary completion date of 2028-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Falls are a leading cause of injury and loss of independence in older adults, with evidence supporting exercise-based interventions and remote monitoring as effective strategies for reducing fall risk. However, adherence and engagement with such programs remain significant challenges. This study builds on prior research demonstrating the feasibility of digital health interventions in rehabilitation and extends it to a structured, remotely monitored Fall Prevention Pathway (FPP). Preliminary work in digital rehabilitation has shown positive engagement and clinical outcomes, supporting the need for further exploration of feasibility, adherence, and cost implications of remotely monitored fall prevention programs.

Eligibility Criteria

Inclusion Criteria: * Adults aged 65-85 years * Community-dwelling individuals classified as low to moderate fall risk based on standardized assessments, (i.e., the Stay Independent Screener) * Ability to ambulate independently or with a single-point cane * Willingness to participate in an 8-week intervention with remote monitoring * Access to a smartphone, tablet, or computer with internet connectivity * Ability to provide informed consent Exclusion Criteria: * Severe cognitive impairment or a diagnosis of dementia that would affect adherence or ability to provide consent * Neurological or vestibular disorders (e.g., Parkinson's disease, multiple sclerosis, history of stroke with residual balance impairment) * Severe comorbidities that significantly impact mobility and function (e.g., recent orthopedic surgery, unstable cardiac conditions) * Significant visual or hearing impairments that prevent engagement with digital health interventions * Non-ambulatory or requiring assistance of another person for mobility

Contact & Investigator

Central Contact

Madeleine E. Hackney, Ph.D.

✉ mehackn@emory.edu

📞 314-412-4852

Principal Investigator

Madeleine E. Hackney, Ph.D.

PRINCIPAL INVESTIGATOR

Emory University

Frequently Asked Questions

Who can join the NCT07824141 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 85 Years, studying Old Age; Debility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07824141 currently recruiting?

Yes, NCT07824141 is actively recruiting participants. Contact the research team at mehackn@emory.edu for enrollment information.

Where is the NCT07824141 trial being conducted?

This trial is being conducted at Atlanta, United States.

Who is sponsoring the NCT07824141 clinical trial?

NCT07824141 is sponsored by Emory University. The principal investigator is Madeleine E. Hackney, Ph.D. at Emory University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology